en

PRODUCT DETAIL

Sunitinib FMK 25 mg tvrdé kapsuly

Code 4826D
MA number 44/0138/20-S
Product Form: cps dur 30x1x25 mg (blis.Al/OPA/Al/PVC-jednotliv.dáv.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Farmak International Sp. z o.o., Poland
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XE Protein kinase inhibitors
L01XE04 Sunitinib
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 19.06.2020
Validity: 19.06.2025
SPC: SPC_Sunitinib FMK 25 mg tvrdé kapsuly_10.2023.pdf  
PIL: PIL_Sunitinib FMK 25 mg tvrdé kapsuly_10.2023.pdf  
Safety feature Yes
Data update: 17.10.2023
eu-flag.png sk-flag.png